| 000 | 01851 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514053115.0 | ||
| 264 | 0 | _c20030121 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/ijc.10836 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aToomey, Deirdre | |
| 245 | 0 | 0 |
_aInfiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cJan 2003 |
||
| 300 |
_a408-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarcinoma, Large Cell _xmetabolism |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xmetabolism |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xmetabolism |
| 650 | 0 | 4 | _aFas Ligand Protein |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aLymphocytes, Tumor-Infiltrating _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aT-Lymphocytes _xmetabolism |
| 700 | 1 | _aSmyth, Gordon | |
| 700 | 1 | _aCondron, Claire | |
| 700 | 1 | _aKelly, James | |
| 700 | 1 | _aByrne, Ann-Marie | |
| 700 | 1 | _aKay, Elaine | |
| 700 | 1 | _aConroy, Ronan M | |
| 700 | 1 | _aBroe, Patrick | |
| 700 | 1 | _aBouchier-Hayes, David | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 103 _gno. 3 _gp. 408-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.10836 _zAvailable from publisher's website |
| 999 |
_c12276656 _d12276656 |
||